Full Description
In this book international experts address a range of key current issues relating to suicide. The opening chapters discuss nosology, definitions, clinical determinants, and conceptual models of the suicide process and consider the evidence regarding potential biomarkers of suicide risk based on neuroscientific research. Adopting a neo-Durkheimian perspective, the role of various social factors in the genesis of suicidal behavior is then explored in depth. Practical user-friendly tools that facilitate risk assessment by clinicians are provided, and detailed consideration is given to efficient and innovative strategies for the prevention of suicide and the treatment of suicidal behavior, such as psychotherapy, psychopharmacological approaches, and effective organization of care, including surveillance and the use of online tools. The final part of the book focuses on the need for and development of a personalized approach within the field of suicide prevention.
Contents
Part I: Diagnostic & Clinical issues : DSM5.- Nomenclature & definitions.- Scales : Use of C-SSRS.- Dimensions related to suicidal behaviour.- Temperament in suicidal behaviour.- Suicidal addiction.- Part II: Models of suicidal process: Interpersonal theory.- Suicidal crisis.- Neurodevelopmental model.- Part III: Biomarkers of suicide: Prospective studies.- Genetics.- Epigenetics.- Social neurocognitions.- Social & psychological.- Biochemical markers.- Translational models.- Part IV: Neo-Durkheimian view: From society to groups at risk: Economic crisis.- Psychiatric disorders: practical assessment.- May a law change society: a Japanese model.- Is it possible to survive in jail.- Is the risk rising in children?.- Is racism a killer?.- Should we talk about religion?.- Part V: Treatments of suicidal behaviour: Surveillance is a powerful tool to prevent suicidal acts.- Preventing suicidality through online tools.- What's wrong with antidepressants?.- Lithium : the key anti-suicide agent.- Antipsychotics.- Anticonvulsants.- Psychotherapy.- Part VI: A need for Personalized Suicidology: Childhood maltreatment.- Early detection in families.- Should we consider the gender?.- Is Pharmacoepidemiology really useful?.- Pharmacogenetics.- Endophenotypes based prevention.
